{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:55:12Z","timestamp":1783137312212,"version":"3.54.6"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL036587"],"award-info":[{"award-number":["P01-HL036587"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11306-020-01757-0","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T17:04:48Z","timestamp":1610989488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sex and race differences of cerebrospinal fluid metabolites in healthy individuals"],"prefix":"10.1007","volume":"17","author":[{"given":"Zackery W.","family":"Reavis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Mirjankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikant","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne R.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Babyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene C.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redford B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Grichnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stafford-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1937-7601","authenticated-orcid":false,"given":"Anastasia","family":"Georgiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"1757_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-0447.1984.tb02488.x","volume":"69","author":"M Asberg","year":"1984","unstructured":"Asberg, M., Bertilsson, L., Martensson, B., Scalia-Tomba, G. P., Thoren, P., & Traskman-Bendz, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica, 69, 201\u2013219. https:\/\/doi.org\/10.1111\/j.1600-0447.1984.tb02488.x.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"1757_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1176\/ajp.137.2.174","volume":"137","author":"PA Berger","year":"1980","unstructured":"Berger, P. A., et al. (1980). CSF monoamine metabolites in depression and schizophrenia. American Journal of Psychiatry, 137, 174\u2013180. https:\/\/doi.org\/10.1176\/ajp.137.2.174.","journal-title":"American Journal of Psychiatry"},{"key":"1757_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1471-4159.1985.tb05451.x","volume":"44","author":"AL Betz","year":"1985","unstructured":"Betz, A. L. (1985). Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. Journal of Neurochemistry, 44, 574\u2013579. https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb05451.x.","journal-title":"Journal of Neurochemistry"},{"key":"1757_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0924-977x(93)90295-w","volume":"3","author":"K Blennow","year":"1993","unstructured":"Blennow, K., et al. (1993). Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18\u201388 years of age. European Neuropsychopharmacology, 3, 55\u201361. https:\/\/doi.org\/10.1016\/0924-977x(93)90295-w.","journal-title":"European Neuropsychopharmacology"},{"key":"1757_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-010-9177-4","volume":"34","author":"HJ Blom","year":"2011","unstructured":"Blom, H. J., & Smulders, Y. (2011). Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. Journal of Inherited Metabolic Disease, 34, 75\u201381. https:\/\/doi.org\/10.1007\/s10545-010-9177-4.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1757_CR6","first-page":"201","volume":"39","author":"AJ Bouckoms","year":"1992","unstructured":"Bouckoms, A. J., et al. (1992). Monoamines in the brain cerebrospinal fluid of facial pain patients. Anesthesia Progress, 39, 201\u2013208.","journal-title":"Anesthesia Progress"},{"key":"1757_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jpsychires.2018.01.004","volume":"99","author":"TD Brewerton","year":"2018","unstructured":"Brewerton, T. D., Putnam, K. T., Lewine, R. R. J., & Risch, S. C. (2018). Seasonality of cerebrospinal fluid monoamine metabolite concentrations and their associations with meteorological variables in humans. Journal of Psychiatric Research, 99, 76\u201382. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.01.004.","journal-title":"Journal of Psychiatric Research"},{"key":"1757_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/geronj\/40.1.23","volume":"40","author":"TP Bridge","year":"1985","unstructured":"Bridge, T. P., Soldo, B. J., Phelps, B. H., Wise, C. D., Francak, M. J., & Wyatt, R. J. (1985). Platelet monoamine oxidase activity: demographic characteristics contribute to enzyme activity variability. J Gerontol, 40, 23\u201328. https:\/\/doi.org\/10.1093\/geronj\/40.1.23.","journal-title":"J Gerontol"},{"key":"1757_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.clinbiochem.2009.02.006","volume":"42","author":"JF Cascalheira","year":"2009","unstructured":"Cascalheira, J. F., et al. (2009). Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer\u2019s type dementia. Clinical Biochemistry, 42, 783\u2013790. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.02.006.","journal-title":"Clinical Biochemistry"},{"key":"1757_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/ijtr.s2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen, Y., & Guillemin, G. J. (2009). Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res, 2, 1\u201319. https:\/\/doi.org\/10.4137\/ijtr.s2097.","journal-title":"Int J Tryptophan Res"},{"key":"1757_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","volume":"34","author":"AL Colin-Gonzalez","year":"2013","unstructured":"Colin-Gonzalez, A. L., Maldonado, P. D., & Santamaria, A. (2013). 3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the central nervous system. Neurotoxicology, 34, 189\u2013204. https:\/\/doi.org\/10.1016\/j.neuro.2012.11.007.","journal-title":"Neurotoxicology"},{"key":"1757_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1017\/S1461145710001689","volume":"14","author":"R Condray","year":"2011","unstructured":"Condray, R., et al. (2011). 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. International Journal of Neuropsychopharmacology, 14, 756\u2013767. https:\/\/doi.org\/10.1017\/S1461145710001689.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"1757_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/0006-3223(93)90103-k","volume":"33","author":"MD De Bellis","year":"1993","unstructured":"De Bellis, M. D., Geracioti, T. D., Jr., Altemus, M., & Kling, M. A. (1993). Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biological Psychiatry, 33, 636\u2013641. https:\/\/doi.org\/10.1016\/0006-3223(93)90103-k.","journal-title":"Biological Psychiatry"},{"key":"1757_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou, L., et al. (2015). The cardiovascular effect of the uremic solute indole-3 acetic acid. Journal of the American Society of Nephrology, 26, 876\u2013887. https:\/\/doi.org\/10.1681\/ASN.2013121283.","journal-title":"Journal of the American Society of Nephrology"},{"key":"1757_CR15","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1098\/rstb.2005.1770","volume":"360","author":"W Droge","year":"2005","unstructured":"Droge, W. (2005). Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philosophical Transactions of the Royal Society B-Biological Sciences, 360, 2355\u20132372. https:\/\/doi.org\/10.1098\/rstb.2005.1770.","journal-title":"Philosophical Transactions of the Royal Society B-Biological Sciences"},{"key":"1757_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0165-0327(02)00011-3","volume":"74","author":"A Ehnvall","year":"2003","unstructured":"Ehnvall, A., Sjogren, M., Zachrisson, O. C., & Agren, H. (2003). Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness. Journal of Affective Disorders, 74, 185\u2013189. https:\/\/doi.org\/10.1016\/s0165-0327(02)00011-3.","journal-title":"Journal of Affective Disorders"},{"key":"1757_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ajcn\/72.1.22","volume":"72","author":"NK Fukagawa","year":"2000","unstructured":"Fukagawa, N. K., Martin, J. M., Wurthmann, A., Prue, A. H., Ebenstein, D., & O\u2019Rourke, B. (2000). Sex-related differences in methionine metabolism and plasma homocysteine concentrations. American Journal of Clinical Nutrition, 72, 22\u201329. https:\/\/doi.org\/10.1093\/ajcn\/72.1.22.","journal-title":"American Journal of Clinical Nutrition"},{"key":"1757_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1520-6394(1997)6:3<89::AID-DA1>3.0.CO;2-0","volume":"6","author":"TD Geracioti Jr","year":"1997","unstructured":"Geracioti, T. D., Jr., et al. (1997). Uncoupling of serotonergic and noradrenergic systems in depression: Preliminary evidence from continuous cerebrospinal fluid sampling. Depress Anxiety, 6, 89\u201394.","journal-title":"Depress Anxiety"},{"key":"1757_CR19","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1176\/ajp.141.12.1533","volume":"141","author":"RH Gerner","year":"1984","unstructured":"Gerner, R. H., et al. (1984). Csf neurochemistry in depressed, manic, and schizophrenic-patients compared with that of normal controls. American Journal of Psychiatry, 141, 1533\u20131540.","journal-title":"American Journal of Psychiatry"},{"key":"1757_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1213\/00000539-199911000-00023","volume":"89","author":"LC Goudas","year":"1999","unstructured":"Goudas, L. C., et al. (1999). Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain. Anesthesia and Analgesia, 89, 1209\u20131215.","journal-title":"Anesthesia and Analgesia"},{"key":"1757_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0304-3940(90)90814-p","volume":"110","author":"MT Heafield","year":"1990","unstructured":"Heafield, M. T., Fearn, S., Steventon, G. B., Waring, R. H., Williams, A. C., & Sturman, S. G. (1990). Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson\u2019s and Alzheimer\u2019s disease. Neuroscience Letters, 110, 216\u2013220. https:\/\/doi.org\/10.1016\/0304-3940(90)90814-p.","journal-title":"Neuroscience Letters"},{"key":"1757_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brainres.2006.04.026","volume":"1095","author":"CL Hou","year":"2006","unstructured":"Hou, C. L., Jia, F. J., Liu, Y., & Li, L. J. (2006). CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Research, 1095, 154\u2013158. https:\/\/doi.org\/10.1016\/j.brainres.2006.04.026.","journal-title":"Brain Research"},{"key":"1757_CR23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1176\/ajp.147.9.1225","volume":"147","author":"JS Jones","year":"1990","unstructured":"Jones, J. S., et al. (1990). Csf 5-Hiaa and Hva concentrations in elderly depressed-patients who attempted-suicide. American Journal of Psychiatry, 147, 1225\u20131227.","journal-title":"American Journal of Psychiatry"},{"key":"1757_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0301-0082(82)90023-5","volume":"19","author":"RS Jones","year":"1982","unstructured":"Jones, R. S. (1982). Tryptamine: A neuromodulator or neurotransmitter in mammalian brain? Progress in Neurobiology, 19, 117\u2013139. https:\/\/doi.org\/10.1016\/0301-0082(82)90023-5.","journal-title":"Progress in Neurobiology"},{"key":"1757_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk, R., et al. (2011). Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement, 7, 309\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2010.06.001.","journal-title":"Alzheimers Dement"},{"key":"1757_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/srep00667","volume":"2","author":"R Kaddurah-Daouk","year":"2012","unstructured":"Kaddurah-Daouk, R., et al. (2012). Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci Rep, 2, 667. https:\/\/doi.org\/10.1038\/srep00667.","journal-title":"Sci Rep"},{"key":"1757_CR27","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1038\/tp.2013.18","volume":"3","author":"R Kaddurah-Daouk","year":"2013","unstructured":"Kaddurah-Daouk, R., et al. (2013). Alterations in metabolic pathways and networks in Alzheimer\u2019s disease. Transl Psychiatry, 3, e244. https:\/\/doi.org\/10.1038\/tp.2013.18.","journal-title":"Transl Psychiatry"},{"key":"1757_CR28","first-page":"877","volume":"17","author":"K Kasa","year":"1982","unstructured":"Kasa, K., Otsuki, S., Yamamoto, M., Sato, M., Kuroda, H., & Ogawa, N. (1982). Cerebrospinal-fluid gamma-aminobutyric acid and homovanillic-acid in depressive-disorders. Biological Psychiatry, 17, 877\u2013883.","journal-title":"Biological Psychiatry"},{"key":"1757_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/IJTR.S16800","volume":"7","author":"ME Kegel","year":"2014","unstructured":"Kegel, M. E., et al. (2014). Imbalanced kynurenine pathway in schizophrenia. International Journal of Tryptophan Research, 7, 15\u201322. https:\/\/doi.org\/10.4137\/IJTR.S16800.","journal-title":"International Journal of Tryptophan Research"},{"key":"1757_CR30","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.190009","author":"YS Kim","year":"2019","unstructured":"Kim, Y. S., Unno, T., Kim, B. Y., & Park, M. S. (2019). Sex Differences in Gut Microbiota. World Journal of Mens Health. https:\/\/doi.org\/10.5534\/wjmh.190009.","journal-title":"World Journal of Mens Health"},{"key":"1757_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archpsyc.1983.01790080081011","volume":"40","author":"SH Koslow","year":"1983","unstructured":"Koslow, S. H., Maas, J. W., Bowden, C. L., Davis, J. M., Hanin, I., & Javaid, J. (1983). Csf and urinary biogenic-amines and metabolites in depression and mania\u2014a controlled, univariate analysis. Archives of General Psychiatry, 40, 999\u20131010.","journal-title":"Archives of General Psychiatry"},{"key":"1757_CR32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","volume":"179","author":"D Krause","year":"2011","unstructured":"Krause, D., et al. (2011). The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. American Journal of Pathology, 179, 1360\u20131372. https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.048.","journal-title":"American Journal of Pathology"},{"key":"1757_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-59745-244-1_10","volume":"358","author":"BS Kristal","year":"2007","unstructured":"Kristal, B. S., Shurubor, Y. I., Kaddurah-Daouk, R., & Matson, W. R. (2007). High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics. Methods in Molecular Biology, 358, 159\u2013174. https:\/\/doi.org\/10.1007\/978-1-59745-244-1_10.","journal-title":"Methods in Molecular Biology"},{"key":"1757_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1385\/1-59259-173-6:185","volume":"186","author":"BS Kristal","year":"2002","unstructured":"Kristal, B. S., Vigneau-Callahan, K., & Matson, W. R. (2002). Simultaneous analysis of multiple redox-active metabolites from biological matrices. Methods in Molecular Biology, 186, 185\u2013194. https:\/\/doi.org\/10.1385\/1-59259-173-6:185.","journal-title":"Methods in Molecular Biology"},{"key":"1757_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/abio.1998.2831","volume":"263","author":"BS Kristal","year":"1998","unstructured":"Kristal, B. S., Vigneau-Callahan, K. E., & Matson, W. R. (1998). Simultaneous analysis of the majority of low-molecular-weight, redox-active compounds from mitochondria. Analytical Biochemistry, 263, 18\u201325. https:\/\/doi.org\/10.1006\/abio.1998.2831.","journal-title":"Analytical Biochemistry"},{"key":"1757_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz, J., et al. (2013). The cystine\/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling, 18, 522\u2013555. https:\/\/doi.org\/10.1089\/ars.2011.4391.","journal-title":"Antioxidants & Redox Signaling"},{"key":"1757_CR37","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1212\/wnl.42.11.2111","volume":"42","author":"PA LeWitt","year":"1992","unstructured":"LeWitt, P. A., et al. (1992). Markers of dopamine metabolism in Parkinson\u2019s disease. The Parkinson Study Group. Neurology, 42, 2111\u20132117. https:\/\/doi.org\/10.1212\/wnl.42.11.2111.","journal-title":"Neurology"},{"key":"1757_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0006-3223(98)00078-x","volume":"45","author":"JT Little","year":"1999","unstructured":"Little, J. T., Ketter, T. A., Mathe, A. A., Frye, M. A., Luckenbaugh, D., & Post, R. M. (1999). Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biological Psychiatry, 45, 285\u2013289. https:\/\/doi.org\/10.1016\/s0006-3223(98)00078-x.","journal-title":"Biological Psychiatry"},{"key":"1757_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/1743132811Y.0000000074","volume":"34","author":"B Liu","year":"2012","unstructured":"Liu, B., Shen, Y., Xiao, K., Tang, Y., Cen, L., & Wei, J. (2012). Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurological Research, 34, 163\u2013171. https:\/\/doi.org\/10.1179\/1743132811Y.0000000074.","journal-title":"Neurological Research"},{"key":"1757_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41398-017-0056-8","volume":"8","author":"D Liu","year":"2018","unstructured":"Liu, D., et al. (2018). Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Transl Psychiatry, 8, 10. https:\/\/doi.org\/10.1038\/s41398-017-0056-8.","journal-title":"Transl Psychiatry"},{"key":"1757_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/0024-3205(89)90359-7","volume":"44","author":"JB Lucot","year":"1989","unstructured":"Lucot, J. B., Crampton, G. H., Matson, W. R., & Gamache, P. H. (1989). Cerebrospinal fluid constituents of cat vary with susceptibility to motion sickness. Life Sciences, 44, 1239\u20131245. https:\/\/doi.org\/10.1016\/0024-3205(89)90359-7.","journal-title":"Life Sciences"},{"key":"1757_CR42","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/clinchem\/30.9.1477","volume":"30","author":"WR Matson","year":"1984","unstructured":"Matson, W. R., Langlais, P., Volicer, L., Gamache, P. H., Bird, E., & Mark, K. A. (1984). n-Electrode three-dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters. Clinical Chemistry, 30, 1477\u20131488.","journal-title":"Clinical Chemistry"},{"key":"1757_CR43","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/0006-3223(91)90253-i","volume":"29","author":"SE Molchan","year":"1991","unstructured":"Molchan, S. E., et al. (1991). CSF monoamine metabolites and somatostatin in Alzheimer\u2019s disease and major depression. Biological Psychiatry, 29, 1110\u20131118. https:\/\/doi.org\/10.1016\/0006-3223(91)90253-i.","journal-title":"Biological Psychiatry"},{"key":"1757_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0006-2944(76)90031-4","volume":"16","author":"DL Murphy","year":"1976","unstructured":"Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L., & Wyatt, R. J. (1976). Platelet and plasma amine oxidase activity in 680 normals\u2014sex and age-differences and stability over time. Biochemical Medicine, 16, 254\u2013265. https:\/\/doi.org\/10.1016\/0006-2944(76)90031-4.","journal-title":"Biochemical Medicine"},{"key":"1757_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-018-0119-x","volume":"6","author":"Y Nagata","year":"2018","unstructured":"Nagata, Y., et al. (2018). Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort. Biomark Research, 6, 5. https:\/\/doi.org\/10.1186\/s40364-018-0119-x.","journal-title":"Biomark Research"},{"key":"1757_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpsychires.2005.12.001","volume":"41","author":"LK Nilsson","year":"2007","unstructured":"Nilsson, L. K., Nordin, C., Jonsson, E. G., Engberg, G., Linderholm, K. R., & Erhardt, S. (2007). Cerebrospinal fluid kynurenic acid in male and female controls\u2014Correlation with monoamine metabolites and influences of confounding factors. Journal of Psychiatric Research, 41, 144\u2013151. https:\/\/doi.org\/10.1016\/j.jpsychires.2005.12.001.","journal-title":"Journal of Psychiatric Research"},{"key":"1757_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cem.1017","volume":"20","author":"L N\u00f8rgaard","year":"2006","unstructured":"N\u00f8rgaard, L., Bro, R., Westad, F., & Engelsen, S. B. (2006). A modification of canonical variates analysis to handle highly collinear multivariate data. Journal of Chemometrics, 20, 425\u2013435.","journal-title":"Journal of Chemometrics"},{"key":"1757_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O'Mahony","year":"2015","unstructured":"O\u2019Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, 32\u201348. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.027.","journal-title":"Behavioural Brain Research"},{"key":"1757_CR49","doi-asserted-by":"publisher","first-page":"e101763","DOI":"10.1371\/journal.pone.0101763","volume":"9","author":"E Olivola","year":"2014","unstructured":"Olivola, E., et al. (2014). Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart. PLoS ONE, 9, e101763. https:\/\/doi.org\/10.1371\/journal.pone.0101763.","journal-title":"PLoS ONE"},{"key":"1757_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-1781(81)90004-4","volume":"4","author":"L Oreland","year":"1981","unstructured":"Oreland, L., et al. (1981). Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Research, 4, 21\u201329. https:\/\/doi.org\/10.1016\/0165-1781(81)90004-4.","journal-title":"Psychiatry Research"},{"key":"1757_CR51","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00415-012-6440-7","volume":"259","author":"S Paganoni","year":"2012","unstructured":"Paganoni, S., et al. (2012). Uric acid levels predict survival in men with amyotrophic lateral sclerosis. Journal of Neurology, 259, 1923\u20131928. https:\/\/doi.org\/10.1007\/s00415-012-6440-7.","journal-title":"Journal of Neurology"},{"key":"1757_CR52","first-page":"193","volume":"33","author":"V Palaniappun","year":"1991","unstructured":"Palaniappun, V., Ramachandran, V., & Somasundaram, O. (1991). Norepinephrine and serotonin metabolism and clinical response to combined imipramine and amitriptyline therapy in depression. Indian Journal of Psychiatry, 33, 193\u2013199.","journal-title":"Indian Journal of Psychiatry"},{"key":"1757_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2105-13-120","volume":"13","author":"AK Petersen","year":"2012","unstructured":"Petersen, A. K., et al. (2012). On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics, 13, 120. https:\/\/doi.org\/10.1186\/1471-2105-13-120.","journal-title":"BMC Bioinformatics"},{"key":"1757_CR54","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.179.4077.1002","volume":"179","author":"RM Post","year":"1973","unstructured":"Post, R. M., Gordon, E. K., Goodwin, F. K., & Bunney, W. E., Jr. (1973). Central norepinephrine metabolism in affective illness: MHPG in the cerebrospinal fluid. Science, 179, 1002\u20131003. https:\/\/doi.org\/10.1126\/science.179.4077.1002.","journal-title":"Science"},{"key":"1757_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0006-3223(92)90198-9","volume":"31","author":"PL Reddy","year":"1992","unstructured":"Reddy, P. L., Khanna, S., Subhash, M. N., Channabasavanna, S. M., & Rao, B. S. (1992). CSF amine metabolites in depression. Biological Psychiatry, 31, 112\u2013118. https:\/\/doi.org\/10.1016\/0006-3223(92)90198-9.","journal-title":"Biological Psychiatry"},{"key":"1757_CR56","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","volume":"68","author":"GZ Reus","year":"2015","unstructured":"Reus, G. Z., Jansen, K., Titus, S., Carvalho, A. F., Gabbay, V., & Quevedo, J. (2015). Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies. Journal of Psychiatric Research, 68, 316\u2013328. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.05.007.","journal-title":"Journal of Psychiatric Research"},{"key":"1757_CR57","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1176\/ajp.143.12.1539","volume":"143","author":"A Roy","year":"1986","unstructured":"Roy, A., et al. (1986). Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. American Journal of Psychiatry, 143, 1539\u20131545. https:\/\/doi.org\/10.1176\/ajp.143.12.1539.","journal-title":"American Journal of Psychiatry"},{"key":"1757_CR58","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archpsyc.1988.01800330081010","volume":"45","author":"A Roy","year":"1988","unstructured":"Roy, A., Pickar, D., De Jong, J., Karoum, F., & Linnoila, M. (1988). Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Archives of General Psychiatry, 45, 849\u2013857. https:\/\/doi.org\/10.1001\/archpsyc.1988.01800330081010.","journal-title":"Archives of General Psychiatry"},{"key":"1757_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-3223(89)90181-9","volume":"25","author":"A Roy","year":"1989","unstructured":"Roy, A., Pickar, D., De Jong, J., Karoum, F., & Linnoila, M. (1989). Suicidal behavior in depression: relationship to noradrenergic function. Biological Psychiatry, 25, 341\u2013350. https:\/\/doi.org\/10.1016\/0006-3223(89)90181-9.","journal-title":"Biological Psychiatry"},{"key":"1757_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11306-005-4810-1","volume":"1","author":"S Rozen","year":"2005","unstructured":"Rozen, S., et al. (2005). Metabolomic analysis and signatures in motor neuron disease. Metabolomics, 1, 101\u2013108. https:\/\/doi.org\/10.1007\/s11306-005-4810-1.","journal-title":"Metabolomics"},{"key":"1757_CR61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","volume":"52","author":"J Savitz","year":"2015","unstructured":"Savitz, J., et al. (2015). Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology, 52, 200\u2013211. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.015.","journal-title":"Psychoneuroendocrinology"},{"key":"1757_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2005.10.002","volume":"90","author":"L Sher","year":"2006","unstructured":"Sher, L., et al. (2006). Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. Journal of Affective Disorders, 90, 83\u201389. https:\/\/doi.org\/10.1016\/j.jad.2005.10.002.","journal-title":"Journal of Affective Disorders"},{"key":"1757_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.euroneuro.2004.09.009","volume":"15","author":"L Sher","year":"2005","unstructured":"Sher, L., et al. (2005). Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder. European Neuropsychopharmacology, 15, 203\u2013209. https:\/\/doi.org\/10.1016\/j.euroneuro.2004.09.009.","journal-title":"European Neuropsychopharmacology"},{"key":"1757_CR64","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/sj.npp.1300231","volume":"28","author":"L Sher","year":"2003","unstructured":"Sher, L., et al. (2003). Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism. Neuropsychopharmacology, 28, 1712\u20131719. https:\/\/doi.org\/10.1038\/sj.npp.1300231.","journal-title":"Neuropsychopharmacology"},{"key":"1757_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/abio.2001.5568","volume":"302","author":"H Shi","year":"2002","unstructured":"Shi, H., Vigneau-Callahan, K. E., Matson, W. R., & Kristal, B. S. (2002). Attention to relative response across sequential electrodes improves quantitation of coulometric array. Analytical Biochemistry, 302, 239\u2013245. https:\/\/doi.org\/10.1006\/abio.2001.5568.","journal-title":"Analytical Biochemistry"},{"key":"1757_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11306-005-4431-8","volume":"1","author":"YI Shurubor","year":"2005","unstructured":"Shurubor, Y. I., Matson, W. R., Martin, R. J., & Kristal, B. S. (2005). Relative contribution of specific sources of systematic errors and analytical imprecision to metabolite analysis by HPLC\u2013ECD. Metabolomics, 1, 159\u2013168. https:\/\/doi.org\/10.1007\/s11306-005-4431-8.","journal-title":"Metabolomics"},{"key":"1757_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(97)00840-9","volume":"238","author":"JF Stover","year":"1997","unstructured":"Stover, J. F., Lowitzsch, K., & Kempski, O. S. (1997). Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Neuroscience Letters, 238, 25\u201328. https:\/\/doi.org\/10.1016\/S0304-3940(97)00840-9.","journal-title":"Neuroscience Letters"},{"key":"1757_CR68","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.biopsych.2005.11.022","volume":"60","author":"GM Sullivan","year":"2006","unstructured":"Sullivan, G. M., Mann, J. J., Oquendo, M. A., Lo, E. S., Cooper, T. B., & Gorman, J. M. (2006a). Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biological Psychiatry, 60, 500\u2013506. https:\/\/doi.org\/10.1016\/j.biopsych.2005.11.022.","journal-title":"Biological Psychiatry"},{"key":"1757_CR69","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S1461145705006231","volume":"9","author":"GM Sullivan","year":"2006","unstructured":"Sullivan, G. M., Oquendo, M. A., Huang, Y. Y., & Mann, J. J. (2006b). Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. International Journal of Neuropsychopharmacology, 9, 547\u2013556. https:\/\/doi.org\/10.1017\/S1461145705006231.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"1757_CR70","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/s0006-3223(98)00172-3","volume":"45","author":"AC Swann","year":"1999","unstructured":"Swann, A. C., Katz, M. M., Bowden, C. L., Berman, N. G., & Stokes, P. E. (1999). Psychomotor performance and monoamine function in bipolar and unipolar affective disorders. Biological Psychiatry, 45, 979\u2013988. https:\/\/doi.org\/10.1016\/s0006-3223(98)00172-3.","journal-title":"Biological Psychiatry"},{"key":"1757_CR71","doi-asserted-by":"publisher","first-page":"e69130","DOI":"10.1371\/journal.pone.0069130","volume":"8","author":"H Tabunoki","year":"2013","unstructured":"Tabunoki, H., et al. (2013). Identification of key uric acid synthesis pathway in a unique mutant silkworm Bombyx mori model of Parkinson\u2019s disease. PLoS ONE, 8, e69130. https:\/\/doi.org\/10.1371\/journal.pone.0069130.","journal-title":"PLoS ONE"},{"key":"1757_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10010033","author":"R Vanholder","year":"2018","unstructured":"Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018). Biochemical and clinical impact of organic uremic retention solutes: A comprehensive update. Toxins (Basel),. https:\/\/doi.org\/10.3390\/toxins10010033.","journal-title":"Toxins (Basel)"},{"key":"1757_CR73","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/archneur.1985.04060110040013","volume":"42","author":"L Volicer","year":"1985","unstructured":"Volicer, L., Langlais, P. J., Matson, W. R., Mark, K. A., & Gamache, P. H. (1985). Serotoninergic system in dementia of the Alzheimer type: abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid. Archives of Neurology, 42, 1158\u20131161. https:\/\/doi.org\/10.1001\/archneur.1985.04060110040013.","journal-title":"Archives of Neurology"},{"key":"1757_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1600-0447.1988.tb06382.x","volume":"78","author":"HG Westenberg","year":"1988","unstructured":"Westenberg, H. G., & Verhoeven, W. M. (1988). CSF monoamine metabolites in patients and controls: Support for a bimodal distribution in major affective disorders. Acta Psychiatrica Scandinavica, 78, 541\u2013549. https:\/\/doi.org\/10.1111\/j.1600-0447.1988.tb06382.x.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"1757_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-0327(88)90051-1","volume":"14","author":"E Widerlov","year":"1988","unstructured":"Widerlov, E., Bissette, G., & Nemeroff, C. B. (1988). Monoamine metabolites, corticotropin releasing-factor and somatostatin as Csf markers in depressed-patients. Journal of Affective Disorders, 14, 99\u2013107. https:\/\/doi.org\/10.1016\/0165-0327(88)90051-1.","journal-title":"Journal of Affective Disorders"},{"key":"1757_CR76","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.npp.1300054","volume":"28","author":"RB Williams","year":"2003","unstructured":"Williams, R. B., et al. (2003). Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology, 28, 533\u2013541. https:\/\/doi.org\/10.1038\/sj.npp.1300054.","journal-title":"Neuropsychopharmacology"},{"key":"1757_CR77","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.4088\/JCP.16m11144","volume":"78","author":"HS Yoon","year":"2017","unstructured":"Yoon, H. S., et al. (2017). Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variables in major depressive disorder. Journal of Clinical Psychiatry, 78, e947\u2013e956. https:\/\/doi.org\/10.4088\/JCP.16m11144.","journal-title":"Journal of Clinical Psychiatry"},{"key":"1757_CR78","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1471-4159.1980.tb09944.x","volume":"34","author":"SN Young","year":"1980","unstructured":"Young, S. N., Anderson, G. M., Gauthier, S., & Purdy, W. C. (1980a). The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. Journal of Neurochemistry, 34, 1087\u20131092. https:\/\/doi.org\/10.1111\/j.1471-4159.1980.tb09944.x.","journal-title":"Journal of Neurochemistry"},{"key":"1757_CR79","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1471-4159.1980.tb06598.x","volume":"34","author":"SN Young","year":"1980","unstructured":"Young, S. N., Anderson, G. M., & Purdy, W. C. (1980b). Indoleamine metabolism in rat brain studied through measurements of tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in cerebrospinal fluid. Journal of Neurochemistry, 34, 309\u2013315. https:\/\/doi.org\/10.1111\/j.1471-4159.1980.tb06598.x.","journal-title":"Journal of Neurochemistry"}],"updated-by":[{"DOI":"10.1007\/s11306-021-01809-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000}}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-020-01757-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T02:16:30Z","timestamp":1627697790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-020-01757-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s11306-020-01757-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11306-021-01809-z","asserted-by":"object"}]},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"value":"1573-3882","type":"print"},{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11306-021-01809-z","URL":"https:\/\/doi.org\/10.1007\/s11306-021-01809-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Redford Williams holds a U.S. patent on the use of 5HTTLPR L allele as a marker of increased cardiovascular disease risk. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Duke University Medical Center Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The present study was conducted at Duke University Medical Center, and all subjects gave informed consent prior to their participation in the study using a consent form approved by the Duke University Medical Center Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (the results presented contain no identifiable information).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"13"}}